Cero Therapeutics Holdings, Inc. SC 13D and SC 13D/A reports

Location
201 Haskins Way, Suite 230, South San Francisco, California
State of incorporation
Delaware
Fiscal year end
December 31
Data updated at
5/17/2024, 05:11 PM
Form type Sec Links Description Filing date Reporting date
SC 13D/A Report AMENDMENT NO. 1 TO SCHEDULE 13D Feb 20, 2024
SC 13D Report SC 13D Feb 1, 2023